Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Eledon Pharmaceuticals, Inc. - Common Stock (NQ: ELDN ) 4.350 -0.020 (-0.46%) Streaming Delayed Price Updated: 4:00 PM EST, Dec 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 514,172 Open 4.310 Bid (Size) 3.570 (1) Ask (Size) 4.630 (4) Prev. Close 4.370 Today's Range 4.200 - 4.400 52wk Range 1.520 - 5.540 Shares Outstanding 22,506,956 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results November 12, 2024 From Eledon Pharmaceuticals, Inc. Via GlobeNewswire Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference November 06, 2024 From Eledon Pharmaceuticals, Inc. Via GlobeNewswire Performance YTD +131.38% +131.38% 1 Month +2.11% +2.11% 3 Month +74.70% +74.70% 6 Month +64.77% +64.77% 1 Year +133.87% +133.87% More News Read More David-Alexandre (‘DA’) Gros, CEO of Eledon Pharmaceuticals Inc. (NASDAQ: ELDN), to Present at NobleCon20 November 06, 2024 Via Investor Brand Network 12 Health Care Stocks Moving In Wednesday's After-Market Session October 30, 2024 Via Benzinga Eledon Pharmaceuticals Inc. (NASDAQ: ELDN) Leading the Way in Monday Trading Based on Percentage Gain April 22, 2024 Via Investor Brand Network Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants October 29, 2024 From Eledon Pharmaceuticals, Inc. Via GlobeNewswire Eledon Pharmaceuticals Announces Positive Initial Data from Subjects with Type 1 Diabetes Treated with Tegoprubart as Part of an Immunosuppression Regimen Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine October 29, 2024 From Eledon Pharmaceuticals, Inc. Via GlobeNewswire Eledon Pharmaceuticals to Present at the Cantor Global Healthcare Conference September 11, 2024 From Eledon Pharmaceuticals, Inc. Via GlobeNewswire Eledon Announces Completion of Enrollment in Phase 2 BESTOW Clinical Trial Assessing Tegoprubart for Prevention of Organ Rejection in Kidney Transplant Patients September 04, 2024 From Eledon Pharmaceuticals, Inc. Via GlobeNewswire ELDN Stock Earnings: Eledon Pharma Misses EPS for Q2 2024 August 19, 2024 Via InvestorPlace Eledon Pharmaceuticals Reports Preliminary Second Quarter 2024 Operating Results August 14, 2024 From Eledon Pharmaceuticals, Inc. Via GlobeNewswire Eledon Provides Enrollment Update for Phase 2 BESTOW Trial Assessing Tegoprubart for the Prevention of Organ Rejection July 29, 2024 From Eledon Pharmaceuticals, Inc. Via GlobeNewswire Eledon to Participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism July 02, 2024 From Eledon Pharmaceuticals, Inc. Via GlobeNewswire Penny Stock Picks: 3 Companies Poised to Graduate to the Big Leagues June 17, 2024 Via InvestorPlace 3 High-Potential Penny Stocks to Turn $1000 into $1 Million: June 2024 June 11, 2024 Via InvestorPlace Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation June 03, 2024 From Eledon Pharmaceuticals, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's After-Market Session May 17, 2024 Via Benzinga ELDN Stock Earnings: Eledon Pharma Beats EPS for Q1 2024 May 09, 2024 Via InvestorPlace Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results May 09, 2024 From Eledon Pharmaceuticals, Inc. Via GlobeNewswire Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress May 09, 2024 From Eledon Pharmaceuticals, Inc. Via GlobeNewswire Nano-Cap Eledon Pharmaceuticals' Investigational Drug Shows Safety In Early Organ Transplant Study, Analyst Boosts Forecast On Increased Confidence May 07, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 07, 2024 Via Benzinga Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection May 07, 2024 From Eledon Pharmaceuticals, Inc. Via GlobeNewswire Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement May 07, 2024 From Eledon Pharmaceuticals, Inc. Via GlobeNewswire ELDN Stock Earnings: Eledon Pharma Beats EPS for Q4 2023 March 28, 2024 Via InvestorPlace Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
